mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the OvarySeiji Mabuchi, Tadashi Kimura, Chiaki Kawase et al.|Clinical Cancer Research|2009Cited by 155
Vascular Endothelial Growth Factor Is a Promising Therapeutic Target for the Treatment of Clear Cell Carcinoma of the OvarySeiji Mabuchi, Tadashi Kimura, Chiaki Kawase et al.|Molecular Cancer Therapeutics|2010Cited by 88
The Activity of Trabectedin As a Single Agent or in Combination with Everolimus for Clear Cell Carcinoma of the OvarySeiji Mabuchi, Tadashi Kimura, Takeshi Hisamatsu et al.|Clinical Cancer Research|2011Cited by 37
Supplementary Figure S1 from The Activity of Trabectedin As a Single Agent or in Combination with Everolimus for Clear Cell Carcinoma of the OvarySeiji Mabuchi, Tadashi Kimura, Takeshi Hisamatsu et al.|Unknown|2023Cited by 0
Data from The Activity of Trabectedin As a Single Agent or in Combination with Everolimus for Clear Cell Carcinoma of the OvarySeiji Mabuchi, Tadashi Kimura, Kenjiro Sawada et al.|Unknown|2023Cited by 0